Ryan Allway August 17th, 2021 App, Psychedelics, Top Story Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Silo Pharma Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the therapeutic potential of psychedelics, recently announced that the U.S.... Read more
Silo Pharma Takes Next Step in Bringing Homing Peptide Tech to $30+ Billion RA Market
Uncategorized July 23, 2021
Ryan Allway July 23rd, 2021 Psychedelics, Top Story, Uncategorized Rheumatoid arthritis, or RA, is an autoimmune and inflammatory disease that causes painful swelling in joints in the hands, wrists, and knees. While medications can slow the disease and prevent joint deformity, there is no cure for the condition, and... Read more
